Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on nickel catalyzed. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113603636A details a cost-effective Nickel-catalyzed route for 2-isopropyl-3-amino-4-methylpyridine, offering significant supply chain advantages.
Patent CN118307453A details a nickel-catalyzed route for alkylaryl sulfoxides, offering cost-effective and scalable solutions for pharmaceutical intermediate manufacturing.
Patent CN113735669A details a cost-effective nickel-catalyzed method for constructing quaternary carbon chiral centers in alpha-acyllactams, offering significant supply chain advantages for pharmaceutical manufacturing.
Patent CN108586547B reveals stable nickel catalysts for 1,1-diarylethanes. Offers cost reduction and supply chain reliability for fine chemical intermediates.
Novel nickel-catalyzed direct cross-coupling of aryl fluorosulfates and bromides. Reduces steps, avoids toxic reagents. Reliable pharma intermediate supplier.
Patent CN114874127B details a cost-effective nickel-catalyzed method for difluorocarbonylated indolones, offering significant supply chain and purity advantages.
Patent CN106279063B details a novel iron-nickel catalyzed route for phenothiazine compounds offering high purity and scalable manufacturing for global pharmaceutical intermediate supply chains.
Patent CN114524795A details a high-yield Rhodomyrtone synthesis eliminating column chromatography. Achieves 34.6% total yield and 99.8% purity for scalable API manufacturing.
Patent CN1436780A details a novel nickel-catalyzed coupling route for 2,3,3',4'-biphenyltetracarboxylic dianhydride, offering cost reduction in electronic chemical manufacturing and scalable production.
Patent CN110724033B reveals a base-free nickel-catalyzed epoxide opening. Offers cost reduction in pharmaceutical intermediate manufacturing with broad substrate scope.
Novel nickel-catalyzed synthesis of beta-iododifluoroacetone derivatives offers high yield and scalability for pharmaceutical intermediates manufacturing supply chain cost reduction.
Patent CN114890912B reveals efficient nickel-catalyzed synthesis of fluorinated intermediates, offering cost reduction and scalable supply chain solutions for pharma.
Patent CN115784826B reveals nickel-catalyzed olefin functionalization. Offers cost reduction in pharmaceutical intermediate manufacturing with high selectivity.
Novel nickel-catalyzed oxidation route for Acalabrutinib key intermediate reduces cost and pollution while ensuring high purity for pharma supply chains.
Patent CN109293700B discloses a novel chiral ligand enabling ultra-low nickel loading for enantioselective cyclization, offering significant cost and efficiency advantages.
Patent CN103086850A reveals a novel Ni-catalyzed route for CF2O-containing compounds, offering significant cost reduction in electronic chemical manufacturing and improved scalability.
Patent CN113105374A reveals a nickel-catalyzed method for alkylamine derivatives, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel Ni-catalyzed desulfitative coupling of sulfonyl chlorides offers high yield and broad scope. A cost-effective route for API intermediates and fine chemicals.
Novel Ni-catalyzed method for trifluoroethylation using cheap 2-chloro-1,1,1-trifluoroethane. Mild conditions, high yield, suitable for pharma intermediates.
Novel Ni-catalyzed route for Bilastine intermediate II. High yield, low cost, scalable process replacing Palladium methods for pharmaceutical manufacturing.